When price cut cards may help alleviate the stress of substantial drug charges during the short-term, they don't tackle the systemic troubles driving up prescription charges during the U.S. Broader policy variations could tackle the root leads to of mounting drug selling prices, including not enough transparency in pricing as well as the position o